Navigation Links
Phase III Study Evaluating Gilead's Viread for the Treatment of,Chronic Hepatitis B Virus Meets Primary Endpoint

with Hepsera for a median of 49 weeks up to a maximum of 240 weeks. Changes in serum creatinine were observed very commonly in patients pre- and post-transplantation with lamivudine-resistant liver disease and multiple risk factors for changes in renal function who were treated with Hepsera for up to 129 weeks, with a median time on treatment of 19 and 56 weeks, respectively. Clinical and laboratory evidence of exacerbations of hepatitis have occurred after discontinuation of treatment with antiviral therapies for hepatitis B, including Hepsera. Special warnings and precautions for use are included in the package insert regarding monitoring of renal function, post-treatment exacerbations of hepatitis, and the occurrence of lactic acidosis and severe hepatomegaly with steatosis. Dosing instructions for patients with underlying renal impairment and for patients co-infected with HIV are also provided in the package insert, which is available for download online at www.hepsera.com.

About Gilead Sciences

Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company's mission is to advance the care of patients suffering from life-threatening diseases worldwide. Headquartered in Foster City, California, Gilead has operations in North America, Europe and Australia. For more information on Gilead Sciences, please visit the company's website at www.gilead.com or call Gilead Public Affairs at 1-800-GILEAD-5 or 1-650-574-3000.

This press release includes forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995, that are subject to risks, uncertainties and other factors, including risks related to Gilead's ability to successfully commercialize tenofovir DF for chronic hepatitis B. For example, the FDA may not approve tenofovir DF for the treatment of chronic hepatitis B in the United States, and marketing approval, i
'"/>




Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
3. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
4. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
6. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
7. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
8. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
9. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
10. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
11. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
Post Your Comments:
(Date:6/29/2015)... The global insulin market is ... new study by Grand View Research, Inc. Growing global prevalence of ... unmet needs in emerging markets such as India ... two of the most significant growth drivers of this market. Moreover, ... growing global geriatric population base are expected to serve the global ...
(Date:6/29/2015)... 2015  Sorrento Therapeutics, Inc. (NASDAQ: SRNE ; ... the Russell 2000® Small Cap, Russell 3000®, and Russell ... the close of trading on June 26, 2015 when ... U.S. and global indexes. Sorrento is already a member ... the Russell Indexes. Russell indexes are ...
(Date:6/29/2015)... SOUTH EASTON, Mass. , June 29, 2015 ... the "Company"), a leader in the development and ... sample preparation solutions to the worldwide life sciences ... of the Institute of Molecular Systems Biology, ETH ... the proteomic profiling and classification of prostate cancer ...
Breaking Medicine Technology:Insulin Market To Reach $47.54 Billion By 2020: Grand View Research, Inc. 2Insulin Market To Reach $47.54 Billion By 2020: Grand View Research, Inc. 3Insulin Market To Reach $47.54 Billion By 2020: Grand View Research, Inc. 4Sorrento Added to Russell 2000 Small Cap, Russell 3000 and Global Indexes 2Sorrento Added to Russell 2000 Small Cap, Russell 3000 and Global Indexes 3Better Classification of Prostate Cancer Tissue Biopsy Samples Enabled by Pressure BioSciences' PCT Platform 2Better Classification of Prostate Cancer Tissue Biopsy Samples Enabled by Pressure BioSciences' PCT Platform 3Better Classification of Prostate Cancer Tissue Biopsy Samples Enabled by Pressure BioSciences' PCT Platform 4
... to be delivered at the Drug Information Association (DIA) ... Geneva, Switzerland, experts from PAREXEL International Corporation ... services provider, will address advanced approaches to help the ... Experts from PAREXEL will be available at ...
... DUBLIN, Ireland, March 4, 2011 Warner Chilcott plc (Nasdaq: ... President and Chief Financial Officer Paul Herendeen is scheduled to ... Tuesday, March 8th at 12:35 p.m. ET.   ... , with an archived replay of the webcast available shortly ...
Cached Medicine Technology:PAREXEL Experts to Present Advanced Approaches to Accelerate Development, Maximize Product Value at DIA EuroMeeting 2PAREXEL Experts to Present Advanced Approaches to Accelerate Development, Maximize Product Value at DIA EuroMeeting 3PAREXEL Experts to Present Advanced Approaches to Accelerate Development, Maximize Product Value at DIA EuroMeeting 4
(Date:6/30/2015)... ... , ... It has become fairly common to purchase fresh broccoli at the ... before cooking. Throwing out radish greens, beet leaves and chard stalks is pretty typical, ... takes a little knowledge and practice to use them. Josie's Organics is ...
(Date:6/30/2015)... ... June 30, 2015 , ... Skin Brushing (also known as Body Brushing) is a wonderful daily ... beautiful as it is more exposed to the elements. , Dry Skin Brushing takes only ... Exfoliate the dead cells and toxins on skin's surface. Skin is the largest organ ...
(Date:6/30/2015)... ... June 30, 2015 , ... Lecrae is quickly developing into one ... Rolling Stone and The New York Times to Billboard Magazine and Variety, among others. ... of the many reasons why so many people are taking notice. , “We are ...
(Date:6/30/2015)... ... June 30, 2015 , ... Medflow, the ... a SaaS electronic health records system from the company exclusively dedicated to helping ... 2.0 delivers an intuitive state-of-the-art solution combining modern cloud technology with Medflow’s proven ...
(Date:6/30/2015)... ... June 30, 2015 , ... “It is never too ... SunGrubbies.com. “We are particularly interested in getting the word out to children because ... surface. We are extremely pleased with our new video which we feel ...
Breaking Medicine News(10 mins):Health News:Whole Vegetable Cooking for Home Cooks: Josie's Organics Encourages Using All Parts of Vegetables – from Root to Stalk – Every Day 2Health News:Whole Vegetable Cooking for Home Cooks: Josie's Organics Encourages Using All Parts of Vegetables – from Root to Stalk – Every Day 3Health News:Whole Vegetable Cooking for Home Cooks: Josie's Organics Encourages Using All Parts of Vegetables – from Root to Stalk – Every Day 4Health News:Back in Stock: Keep Skin and Lymphatic System Healthy with Dry Skin Brushes from Sublime Beauty® 2Health News:Hands of Hope to Present Grammy Award-Winner Lecrae in Concert this August 2Health News:Hands of Hope to Present Grammy Award-Winner Lecrae in Concert this August 3Health News:Medflow Launches MEDFLOW 2.0 EHR – The Cloud-Based Ophthalmology EHR 2Health News:SunGrubbies.com, a Leading Online Retailer of Sun Protection Products, Joins Effort to Promote Sun Safety 2Health News:SunGrubbies.com, a Leading Online Retailer of Sun Protection Products, Joins Effort to Promote Sun Safety 3
... -- Compared to people who don,t smoke, smokers face twice ... that stroke nearly a decade sooner, a Canadian study finds. ... for stroke or heart disease drops to non-smoker levels, the ... deputy director of the Canadian Stroke Network (CSN), in a ...
... 3, 2011 A higher dose of radiation (74 Gy) ... that has spread to the lymph nodes, compared to the ... of a late-breaking randomized study presented at the plenary session, ... Society for Radiation Oncology (ASTRO). "Most radiation oncologists and ...
... HealthDay Reporter , MONDAY, Oct. 3 (HealthDay News) ... general anesthesia may be up to three times more likely ... they grow up, a new study suggests. However, experts ... small children who require more than one surgery. "A ...
... Oct. 3, 2011 Dr. Bruce A. Beutler, the ... Defense at UT Southwestern Medical Center, today shared the Nobel ... their discoveries in how the immune system works. ... Institut de Biologie Molculaire et Cellulaire in France shared half ...
... in Spanish . Roger Gomis, ICREA researcher ... up the spin-off Supragen. With the support of IRB Barcelona and ... is the second biotech company to emerge from the institute since ... the end of 2005. Supragen seeks to develop a diagnostic kit ...
... (HealthDay News) -- People who are easily embarrassed are more ... to a new study. "Moderate levels of embarrassment are ... doctoral student in psychology at the University of California, Berkeley, ... is a good thing, not something you should fight." ...
Cached Medicine News:Health News: Smoking May Double Risk for Stroke 2Health News:Higher radiation dose does not help lung cancer patients live longer 2Health News:Could Surgery, Anesthesia While Very Young Hamper Kids' Development? 2Health News:Could Surgery, Anesthesia While Very Young Hamper Kids' Development? 3Health News:UT Southwestern scientist shares 2011 Nobel Prize in Physiology or Medicine 2Health News:UT Southwestern scientist shares 2011 Nobel Prize in Physiology or Medicine 3Health News:IRB Barcelona spin-off to develop a diagnostic kit and new treatments for metastasis 2Health News:Why It's Good If You're Easily Embarrassed 2
... offers reliable microhematocrit determinations. Although the Microspin ... more affordable than most competitive 6 tube ... spin-downs, and the included reader is adjustable, ... circumstances. Offering quieter operation than many similiar ...
... Pelvic surgery represents one of the ... The Matta Pelvic Plating System offers the ... system for addressing fractures of the pelvis ... world renowned as a premiere pelvic surgeon, ...
Comprehensive range of integrated implants and instruments including - Basic, Small, Mini, Pelvic and Foot Sets....
... Conforming to U.S. and international ... Nephew's TC-100 Screw and Plating System* ... and ease of use for open ... However, the TC-100 system works well ...
Medicine Products: